Drug interactions for the following drug(s)
Applies to: SEROquel 25 MG Oral Tablet <> Depakote 250 MG Delayed Release Oral Tablet
The risk or severity of adverse effects can be increased when Quetiapine is combined with Valproic Acid.
Applies to: Vistaril 50 MG (as hydroxyzine pamoate 85.2 MG) Oral Capsule <> Depakote 250 MG Delayed Release Oral Tablet
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Valproic Acid.
Applies to: SEROquel 25 MG Oral Tablet <> Paxil 12.5 MG 24 HR Extended Release Oral Tablet
Paroxetine may increase the QTc-prolonging activities of Quetiapine.
Applies to: Vistaril 50 MG (as hydroxyzine pamoate 85.2 MG) Oral Capsule <> Paxil 12.5 MG 24 HR Extended Release Oral Tablet
The risk or severity of adverse effects can be increased when Hydroxyzine is combined with Paroxetine.
Applies to: Depakote 250 MG Delayed Release Oral Tablet <> Paxil 12.5 MG 24 HR Extended Release Oral Tablet
The metabolism of Valproic Acid can be decreased when combined with Paroxetine.
Applies to: SEROquel 25 MG Oral Tablet <> Vistaril 50 MG (as hydroxyzine pamoate 85.2 MG) Oral Capsule
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: SEROquel 25 MG Oral Tablet <> Depakote 250 MG Delayed Release Oral Tablet
Drug1 (rxcui = 153638, name = quetiapine 25 MG Oral Tablet [Seroquel], tty = SBD). Drug2 (rxcui = 1099679, name = Divalproex Sodium 250 MG Delayed Release Oral Tablet [Depakote], tty = SBD). Drug1 is resolved to Valproate, Drug2 is resolved to Quetiapine fumarate and interaction asserted in DrugBank between Valproic Acid and Quetiapine. Drug1 is resolved to Valproic Acid, Drug2 is resolved to quetiapine and interaction asserted in DrugBank between Valproic Acid and Quetiapine. Drug1 is resolved to Valproic Acid, Drug2 is resolved to Quetiapine fumarate and interaction asserted in DrugBank between Valproic Acid and Quetiapine. Drug1 is resolved to Valproate, Drug2 is resolved to quetiapine and interaction asserted in DrugBank between Valproic Acid and Quetiapine.
Applies to: Vistaril 50 MG (as hydroxyzine pamoate 85.2 MG) Oral Capsule <> Depakote 250 MG Delayed Release Oral Tablet
Drug1 (rxcui = 995280, name = Hydroxyzine Pamoate 50 MG Oral Capsule [Vistaril], tty = SBD). Drug2 (rxcui = 1099679, name = Divalproex Sodium 250 MG Delayed Release Oral Tablet [Depakote], tty = SBD). Drug1 is resolved to Hydroxyzine, Drug2 is resolved to Valproic Acid and interaction asserted in DrugBank between Hydroxyzine and Valproic Acid. Drug1 is resolved to Hydroxyzine, Drug2 is resolved to Valproate and interaction asserted in DrugBank between Hydroxyzine and Valproic Acid.
Applies to: SEROquel 25 MG Oral Tablet <> Paxil 12.5 MG 24 HR Extended Release Oral Tablet
Drug1 (rxcui = 153638, name = quetiapine 25 MG Oral Tablet [Seroquel], tty = SBD). Drug2 (rxcui = 1738804, name = 24 HR Paroxetine Hydrochloride 12.5 MG Extended Release Oral Tablet [Paxil], tty = SBD). Drug1 is resolved to Paroxetine, Drug2 is resolved to quetiapine and interaction asserted in DrugBank between Paroxetine and Quetiapine. Drug1 is resolved to Paroxetine, Drug2 is resolved to Quetiapine fumarate and interaction asserted in DrugBank between Paroxetine and Quetiapine.
Applies to: Vistaril 50 MG (as hydroxyzine pamoate 85.2 MG) Oral Capsule <> Paxil 12.5 MG 24 HR Extended Release Oral Tablet
Drug1 (rxcui = 995280, name = Hydroxyzine Pamoate 50 MG Oral Capsule [Vistaril], tty = SBD). Drug2 (rxcui = 1738804, name = 24 HR Paroxetine Hydrochloride 12.5 MG Extended Release Oral Tablet [Paxil], tty = SBD). Drug1 is resolved to Hydroxyzine, Drug2 is resolved to Paroxetine and interaction asserted in DrugBank between Hydroxyzine and Paroxetine.
Applies to: Depakote 250 MG Delayed Release Oral Tablet <> Paxil 12.5 MG 24 HR Extended Release Oral Tablet
Drug1 (rxcui = 1099679, name = Divalproex Sodium 250 MG Delayed Release Oral Tablet [Depakote], tty = SBD). Drug2 (rxcui = 1738804, name = 24 HR Paroxetine Hydrochloride 12.5 MG Extended Release Oral Tablet [Paxil], tty = SBD). Drug1 is resolved to Paroxetine, Drug2 is resolved to Valproate and interaction asserted in DrugBank between Paroxetine and Valproic Acid. Drug1 is resolved to Valproic Acid, Drug2 is resolved to Paroxetine and interaction asserted in DrugBank between Valproic Acid and Paroxetine.
Applies to: SEROquel 25 MG Oral Tablet <> Vistaril 50 MG (as hydroxyzine pamoate 85.2 MG) Oral Capsule
Drug1 (rxcui = 153638, name = quetiapine 25 MG Oral Tablet [Seroquel], tty = SBD). Drug2 (rxcui = 995280, name = Hydroxyzine Pamoate 50 MG Oral Capsule [Vistaril], tty = SBD). Drug1 is resolved to Hydroxyzine, Drug2 is resolved to Quetiapine fumarate and interaction asserted in DrugBank between Hydroxyzine and Quetiapine. Drug1 is resolved to Hydroxyzine, Drug2 is resolved to quetiapine and interaction asserted in DrugBank between Hydroxyzine and Quetiapine.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.